Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-12
SponsorKavita Parikh
About this trial
Caregiver-child dyads will be recruited during child's hospital admission for asthma exacerbation. Recruitment sites will be mainly Children's National Hospital Sheikh Zayed campus, as well as regional partners: Holy Cross Hospital, and Mary Washington Hospital. After enrollment, baseline data will be collected from caregiver. Caregiver-child dyads will be randomized (1:1 ratio) into the control arm or intervention arm. Control arm will receive the standard of care after hospital discharge. Intervention arm will receive the SOC plus an asthma navigator support after hospital discharge. Caregivers in both arms will complete data collection surveys (either in-person or via telehealth) at 3-,6-, 9-, and 12- month post enrollment.
Eligibility criteria
Qualifiers
speak English or Spanish
are at least 18 years old
live in the District of Columbia, Maryland, or Virginia (DMV)
have a child aged 4-12 years who is hospitalized due to asthma exacerbation.
Disqualifiers
. Children ages 4-12 years with chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder
. Children ages 4-12 years involved in interventions with behavioral component and/or novel asthma therapeutics will be excluded given overlap with the current intervention
. Children ages 4-12 years in foster care
. Families not residing in the DMV
Trial design
Treatments tested in this trial
- Hospital to Home Transition (H2H)
Treatment groups
340 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kavita Parikh
Lead sponsor
Children's National Research Institute
Sponsor institution
Source ClinicalTrials.gov